Welgus Howard G. — SEC insider filings
SEC reporting owner CIK 1801050. 83 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers the 50 most recent of 83 filings on record, filed 2021-10-05 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 50 legs across 45 filings — 342,771 shares, $6,070,946 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 90.
- Largest priced transaction: sale of 10,000 shares @ $30.21 ($302,133) in Arcutis Biotherapeutics, Inc., filed 2025-12-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | Director | 50 | — | 50 legs · 342,771 sh · $6,070,946 | 90 |
Insider filings — Welgus Howard G.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 822 @ $6.52 · Option exercise (M): 1,018 @ $7.51 · Option exercise (M): 2,254 @ $8.63 · Sale (S): 4,728 @ $28.16 · Option exercise (M): 822 (derivative) @ $0 · Option exercise (M): 1,018 (derivative) @ $0 · +1 more | EDGAR |
| 2026-10-19 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 822 @ $6.52 · Option exercise (M): 1,018 @ $7.51 · Option exercise (M): 2,254 @ $8.63 · Sale (S): 4,728 @ $26.93 · Option exercise (M): 822 (derivative) @ $0 · Option exercise (M): 1,018 (derivative) @ $0 · +1 more | EDGAR |
| 2026-09-17 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 822 @ $6.52 · Option exercise (M): 1,019 @ $7.51 · Option exercise (M): 2,255 @ $8.63 · Sale (S): 4,730 @ $24.18 · Option exercise (M): 822 (derivative) @ $0 · Option exercise (M): 1,019 (derivative) @ $0 · +1 more | EDGAR |
| 2026-08-19 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 822 @ $6.52 · Option exercise (M): 1,019 @ $7.51 · Option exercise (M): 2,255 @ $8.63 · Sale (S): 4,730 @ $26.18 · Option exercise (M): 822 (derivative) @ $0 · Option exercise (M): 1,019 (derivative) @ $0 · +1 more | EDGAR |
| 2026-07-17 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 822 @ $6.52 · Option exercise (M): 1,019 @ $7.51 · Option exercise (M): 2,255 @ $8.63 · Sale (S): 4,730 @ $26.91 · Option exercise (M): 822 (derivative) @ $0 · Option exercise (M): 1,019 (derivative) @ $0 · +1 more | EDGAR |
| 2026-06-17 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 822 @ $6.52 · Option exercise (M): 1,019 @ $7.51 · Option exercise (M): 2,255 @ $8.63 · Sale (S): 4,096 @ $24.41 · Sale (S): 635 @ $25.67 · Option exercise (M): 822 (derivative) @ $0 · +2 more | EDGAR |
| 2026-06-09 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 5,778 @ $0 · Grant/award (A): 16,667 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 7,144 @ $22.99 | EDGAR |
| 2026-04-03 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 10,000 @ $23.88 | EDGAR |
| 2026-03-04 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 10,000 @ $25.65 | EDGAR |
| 2026-02-04 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 10,000 @ $25.05 | EDGAR |
| 2026-01-06 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 10,000 @ $28.96 | EDGAR |
| 2025-12-03 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 10,000 @ $30.21 | EDGAR |
| 2025-11-05 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 10,000 @ $25.27 | EDGAR |
| 2025-10-03 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 9,538 @ $1.68 · Sale (S): 9,538 @ $18.92 · Sale (S): 462 @ $18.92 · Option exercise (M): 9,538 (derivative) @ $0 | EDGAR |
| 2025-09-04 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 10,000 @ $0 · Sale (S): 10,000 @ $15.64 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-08-05 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 6,110 @ $0 · Sale (S): 6,110 @ $14.30 · Option exercise (M): 3,890 @ $0 · Sale (S): 3,890 @ $14.30 · Option exercise (M): 6,110 (derivative) @ $0 · Option exercise (M): 3,890 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 9,208 @ $13.84 | EDGAR |
| 2025-06-20 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 10,139 @ $13.37 | EDGAR |
| 2025-06-16 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 7,609 @ $0 · Grant/award (A): 20,568 (derivative) @ $0 | EDGAR |
| 2025-05-05 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 10,000 @ $14.64 | EDGAR |
| 2025-04-03 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 10,000 @ $15.12 | EDGAR |
| 2025-03-04 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 10,000 @ $13.00 | EDGAR |
| 2025-02-04 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 10,000 @ $12.71 | EDGAR |
| 2025-01-06 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 10,000 @ $14.67 | EDGAR |
| 2024-12-03 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 10,000 @ $12.51 | EDGAR |
| 2024-11-05 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 10,000 @ $8.65 | EDGAR |
| 2024-10-03 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 10,000 @ $9.26 | EDGAR |
| 2024-09-05 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 10,000 @ $10.77 | EDGAR |
| 2024-08-05 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 6,614 @ $1.68 · Sale (S): 6,614 @ $9.87 · Sale (S): 3,386 @ $9.87 · Option exercise (M): 6,614 (derivative) @ $0 | EDGAR |
| 2024-07-02 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 5,681 @ $1.68 · Option exercise (M): 4,319 @ $1.68 · Sale (S): 10,000 @ $9.31 · Option exercise (M): 5,681 (derivative) @ $0 · Option exercise (M): 4,319 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 10,139 @ $0 · Grant/award (A): 27,052 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 3,542 @ $1.68 · Option exercise (M): 6,458 @ $1.68 · Sale (S): 3,542 @ $8 · Sale (S): 6,458 @ $8.01 · Option exercise (M): 3,542 (derivative) @ $0 · Option exercise (M): 6,458 (derivative) @ $0 | EDGAR |
| 2023-06-02 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 4,375 @ $0 · Grant/award (A): 12,220 (derivative) @ $0 | EDGAR |
| 2023-04-18 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 8,500 @ $1.68 · Sale (S): 8,500 @ $13.97 · Option exercise (M): 8,500 (derivative) @ $0 | EDGAR |
| 2023-04-10 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 8,500 @ $1.68 · Sale (S): 8,500 @ $12.01 · Option exercise (M): 8,500 (derivative) @ $0 | EDGAR |
| 2023-02-21 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 8,500 @ $1.68 · Sale (S): 8,500 @ $16.98 · Option exercise (M): 8,500 (derivative) @ $0 | EDGAR |
| 2023-01-18 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 8,500 @ $1.68 · Sale (S): 8,500 @ $13.72 · Option exercise (M): 8,500 (derivative) @ $0 | EDGAR |
| 2022-11-17 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 1,020 @ $1.68 · Sale (S): 3,403 @ $20.01 · Option exercise (M): 1,020 (derivative) @ $0 | EDGAR |
| 2022-10-06 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 6,000 @ $20.29 | EDGAR |
| 2022-08-17 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 6,000 @ $24.80 | EDGAR |
| 2022-07-18 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 6,000 @ $24.40 | EDGAR |
| 2022-06-03 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 4,312 @ $0 · Grant/award (A): 11,796 (derivative) @ $0 | EDGAR |
| 2022-06-02 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 2,500 @ $1.68 · Sale (S): 2,500 @ $20.62 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2022-05-03 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 1,496 @ $0.58 · Option exercise (M): 1,004 @ $1.68 · Sale (S): 2,500 @ $20.44 · Option exercise (M): 1,496 (derivative) @ $0 · Option exercise (M): 1,004 (derivative) @ $0 | EDGAR |
| 2022-04-01 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 7,500 @ $0.58 · Sale (S): 7,500 @ $20.02 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 2,500 @ $0.58 · Sale (S): 2,500 @ $21.21 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2021-12-23 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 2,500 @ $0.58 · Sale (S): 2,500 @ $20.16 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2021-11-03 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 2,500 @ $0.58 · Sale (S): 2,500 @ $21.81 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2021-10-05 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Option exercise (M): 2,500 @ $0.58 · Sale (S): 2,500 @ $23.87 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1801050 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs